Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach (Q61444288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

amyotrophic lateral sclerosis

20 April 2020

main subject

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Venkat S.K. Balagurusamy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Barbara Di Camillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Adriano Chiò

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Orla Hardiman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Bruce Hoff

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Lara M. Mangravite

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jinfeng Xiao

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

9

Merit Cudkowicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

26

Gustavo Stolovitzky

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

18

Thea Norman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

2

Neta Zach

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

15

Melanie L Leitner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

3

Maya Bronfeld

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

5

Nazem Atassi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

10

Donna Dillenberger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

22

Wen-Chieh Fang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Robert Kueffner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Javier Garcia-Garcia

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Joshua Knight

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Guang Li

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Liuxia Wang

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jian Peng

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Chen Yang

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Huan-Jui Chang

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

ALS Stratification Consortium

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

24 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

690

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

20 April 2020

copyright license

start time

24 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The phenotypic variability of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Classifying change and heterogeneity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Controversies and priorities in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Clinical and genetic heterogeneity of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Latent cluster analysis of ALS phenotypes identifies prognostically differing groups

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Stratification of ALS patients' survival: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

The PRO-ACT database: design, initial analyses, and predictive features

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Predicting disease progression in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

The self-assessment trap: can we all be better than average?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Wisdom of crowds for robust gene network inference

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Complete hazard ranking to analyze right-censored data: An ALS survival study.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Disease progression in amyotrophic lateral sclerosis: predictors of survival

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Prognosis in amyotrophic lateral sclerosis: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Factors associated with survival in the National Registry of Veterans with ALS.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Amyotrophic lateral sclerosis: early predictors of prolonged survival

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Uric acid levels predict survival in men with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Sialorrhoea and reversals in ALS functional rating scale.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

What does body mass index measure in amyotrophic lateral sclerosis and why should we care?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Causes of death in a post-mortem series of ALS patients

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

How common are ALS plateaus and reversals?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Functional outcome measures as clinical trial endpoints in ALS.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

ALSFRS-R score and its ratio: a useful predictor for ALS-progression

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Physiology of Geobacter metallireducens under excess and limitation of electron donors. Part I. Batch cultivation with excess of carbon sources.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-018-36873-4

7 January 2021

Tocilizumab infusion therapy normalizes inflammation in sporadic ALS patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30679616

12 December 2020

inferred from PubMed ID database lookup

Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30679616

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41598-018-36873-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30679616%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference